Wnt / Hedgehog / Notch
| CSTコード |
包装 |
希望納入価格（円） |
国内在庫  |
ご登録代理店情報 カスタマー情報にご登録いただいた代理店を表示しています。
ご登録代理店の変更は こちら。 |
| #1007 | 100 μg | 16,000 | |
|
TCF7抗体製品一覧
| 使用目的 | |
| TCF1 (C63D9) Rabbit mAb (#2203) の反応をブロックし、抗体の特異性を確認するために使用 |
IHC-P (paraffin)
Immunohistochemical analysis of paraffin-embedded human lung carcinoma using TCF1 (C63D9) Rabbit mAb #2203 in the presence of control peptide (left) or TCF1 Blocking Peptide (right).
LEF1 and TCF are members of the high mobility group (HMG) DNA binding protein family of transcription factors which consists of the following: Lymphoid enhancer factor 1 (LEF1), T Cell Factor 1 (TCF1), TCF3 and TCF4 (1). LEF1 and TCF1 were originally identified as important factors regulating early lymphoid development (2) that act downstream in Wnt signaling. LEF1 and TCF bind to Wnt response elements to provide docking sites for β-catenin, which translocates to the nucleus to promote the transcription of target genes upon activation of Wnt signaling (3). LEF1 and TCF proteins are dynamically expressed during development and aberrant activation of the Wnt signaling pathway is involved in many types of cancers including colon cancer (4,5).
-
Waterman, M.L. (2004)
Cancer Metastasis Rev.
23, 41-52.
-
Schilham, M.W. and Clevers, H. (1998)
Semin. Immunol.
10, 127-132.
-
Brantjes, H. et al. (2002)
Biol. Chem.
383, 255-261.
-
Reya, T. and Clevers, H. (2005)
Nature
434, 843-850.
-
Logan, C.Y. and Nusse, R. (2004)
Annu. Rev. Cell Dev. Biol.
20, 781-810.
